Alterity Therapeutics (ATHE) Assets (2015 - 2025)

Alterity Therapeutics has reported Assets for 11 years, with the latest figure at $37.4 million in Q4 2025.

• For the quarter ending Q4 2025, Assets rose 441.83% year-over-year to $37.4 million; the trailing twelve-month figure through Dec 2025 stood at $37.4 million (up 441.83% YoY), and the FY2025 full-year result was $29.5 million, up 132.67% from the prior year.
• Assets for Q4 2025 stood at $37.4 million, up from $29.5 million in the prior quarter.
• The five-year high for Assets was $37.4 million in Q4 2025, with the low at $273176.4 in Q2 2023.
• Average Assets over 5 years is $21.1 million, with a median of $23.9 million recorded in 2022.
• Year-over-year, Assets tumbled 99.08% in 2023 and surged 4537.63% in 2024.
• Tracing ATHE's Assets over 5 years: stood at $32.7 million in 2021, then slumped by 32.99% to $21.9 million in 2022, then plunged by 34.13% to $14.4 million in 2023, then sank by 52.26% to $6.9 million in 2024, then soared by 441.83% to $37.4 million in 2025.
• The last three Assets figures came in at $37.4 million (Q4 2025), $29.5 million (Q2 2025), and $6.9 million (Q4 2024), per Business Quant data.

Peer Comparison